日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/09/18 | 日証協 | 118,189株 | -11.59% | 56,800株 | -40.77% | 182,352株 | -6.86% | 20,960株 | +31.82% |
2020/09/11 | 日証協 | 133,689株 | -3.67% | 95,900株 | -0.44% | 195,792株 | 0% | 15,900株 | -38.9% |
2020/09/04 | 日証協 | 138,789株 | -6.27% | 96,320株 | +31.15% | 195,792株 | -4.28% | 26,025株 | +134.46% |
2020/08/28 | 日証協 | 148,069株 | +7.63% | 73,440株 | -21.79% | 204,547株 | +5.57% | 11,100株 | +46.05% |
2020/08/21 | 日証協 | 137,569株 | -0.29% | 93,900株 | +60.79% | 193,747株 | -1.47% | 7,600株 | -2.56% |
2020/08/14 | 日証協 | 137,969株 | -8.44% | 58,400株 | -48.59% | 196,647株 | -3.43% | 7,800株 | -77.13% |
2020/08/07 | 日証協 | 150,689株 | +8.69% | 113,600株 | +11.37% | 203,639株 | +10.74% | 34,108株 | +16.01% |
2020/07/22 | 日証協 | 127,438株 | +15.6% | 34,700株 | -50.29% | 167,890株 | +13.33% | 28,651株 | -51.68% |
2020/07/17 | 日証協 | 110,238株 | -6.43% | 69,800株 | -8.23% | 148,139株 | -5.37% | 59,300株 | +18.84% |
2020/07/10 | 日証協 | 117,818株 | -19.61% | 76,060株 | -25.59% | 156,539株 | -8.64% | 49,900株 | +37.84% |
2020/07/03 | 日証協 | 146,550株 | +9.1% | 102,220株 | +6.81% | 171,350株 | +11.6% | 36,201株 | +156.56% |
2020/06/26 | 日証協 | 134,330株 | -15.76% | 95,700株 | -22.95% | 153,540株 | -14.21% | 14,110株 | -56.85% |
2020/06/12 | 日証協 | 162,429株 | +0.49% | 164,120株 | -12.89% | 191,838株 | -11.74% | 29,900株 | -1.88% |
2020/06/05 | 日証協 | 161,629株 | -17.47% | 188,400株 | +9.15% | 217,366株 | -7.14% | 30,472株 | +295.74% |
2020/05/29 | 日証協 | 195,839株 | -11.05% | 172,600株 | -15.56% | 234,076株 | -8.52% | 7,700株 | -46.97% |
2020/05/22 | 日証協 | 220,167株 | +3.92% | 204,400株 | -9.8% | 255,873株 | +2.59% | 14,520株 | -71.36% |
2020/05/15 | 日証協 | 211,867株 | -7.75% | 226,608株 | +2.33% | 249,403株 | -3.7% | 50,698株 | +318.99% |
2020/05/08 | 日証協 | 229,671株 | +6.37% | 221,452株 | +84.73% | 258,975株 | +3.93% | 12,100株 | -4.72% |
2020/05/01 | 日証協 | 215,919株 | +10.37% | 119,879株 | +31.59% | 249,188株 | -2.43% | 12,700株 | -32.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top